Evolent Health Files DEF 14A Detailing 2024 Executive Compensation
Ticker: EVH · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1628908
Sentiment: neutral
Topics: proxy-statement, executive-compensation, equity-awards
Related Tickers: EVH
TL;DR
Evolent Health's 2024 proxy statement is out, showing exec comp details. Focus on equity awards for Blackley & Williams.
AI Summary
Evolent Health, Inc. filed its DEF 14A on April 25, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation, including awards granted to Seth Blackley and Frank Williams. Specific financial data related to equity awards for the fiscal year 2024 is presented, with adjustments for non-PEO members.
Why It Matters
This filing provides transparency into how Evolent Health compensates its top executives, which can influence investor perception and corporate governance.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine but can reveal significant information about executive compensation and potential shareholder concerns.
Key Numbers
- 2024 — Fiscal Year (Reporting period for executive compensation details.)
- 20250425 — Filing Date (Date the DEF 14A was submitted to the SEC.)
Key Players & Entities
- Evolent Health, Inc. (company) — Filer
- Seth Blackley (person) — Executive/Director
- Frank Williams (person) — Executive/Director
- 2024-12-31 (date) — Fiscal Year End
- 20250425 (date) — Filing Date
FAQ
What is the total compensation for Seth Blackley in fiscal year 2024?
The filing details equity awards granted to Seth Blackley for the fiscal year 2024, but the total compensation figure is not explicitly stated in the provided excerpt.
What types of equity awards were granted to Evolent Health executives?
The filing mentions 'EqtyAwrdsInSummryCompstnTblForAplblYr' and 'EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTbl', indicating summary compensation table equity awards and adjustments.
Who are the key individuals mentioned in relation to executive compensation?
Seth Blackley and Frank Williams are specifically mentioned in relation to executive compensation and equity awards.
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or proxy statement, is used to solicit shareholder votes and provide information on matters such as director elections and executive compensation.
When is Evolent Health's fiscal year end?
Evolent Health's fiscal year ends on December 31st.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 by Seth Blackley regarding Evolent Health, Inc. (EVH).